Brief: Spago Nanomedical Applies For Extended Patent Protection For Tumorad®
Oct 24 (Reuters) - Spago Nanomedical AB (publ)
SPAGO.ST :
* SPAGO NANOMEDICAL APPLIES FOR EXTENDED PATENT PROTECTION
FOR
TUMORAD®
* ANNOUNCES PUBLICATION OF FOUR NEW PATENT APPLICATIONS
FILED WITH
EUROPEAN PATENT OFFICE
* IF GRANTED, TUMORAD WILL RECEIVE PROTECTION IN ALL
STRATEGICALLY
KEY MARKETS, INCLUDING EU, US AND JAPAN, UNTIL AT LEAST 2042
Source text for Eikon: ID:nMFN3sLtWr
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose